Public injecting drug use and the social production of harmful practice in high-rise tower blocks (London, UK): A Lefebvrian analysis

Health and Place

Volumn 17, Issue 3, 2011, Pages 717-726

  Parkin, Stephen ^a   Coomber, Ross ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Henri Lefebvre; High rise tower blocks; Injecting related harm reduction; Public injecting drug use; Right to the city

Indexed keywords

ILLICIT DRUG;

CONCEPTUAL FRAMEWORK; DRUG USER; HEALTH RISK; QUESTIONNAIRE SURVEY; SOCIAL HOUSING; URBAN AREA;

ADULT; ARTICLE; CONCEPTUAL FRAMEWORK; DRUG ABUSE; ENVIRONMENT; FEMALE; HARM REDUCTION; HAZARD; HEALTH HAZARD; HOUSING; HUMAN; INTERVIEW; MALE; PRIORITY JOURNAL; PUBLIC INJECTING DRUG USE; QUALITATIVE RESEARCH; SOCIAL BEHAVIOR; UNITED KINGDOM; URBAN AREA;

EID: 79955717544     PISSN: 13538292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthplace.2011.02.001     Document Type: Article

References (56)

1. Beltrano V. Informal publics: observations on how the creative act of street-vending asserts a collective right to the city. Canadian Architect 2009, 3:42.
2. Bourgois P., Lettiere M., Quesada J. Social misery and the sanctions of substance abuse: confronting HIV risk amongst homeless heroin addicts in San Francisco. Social Problems 1997, 44:155-173.
3. Bourgois P., Schonberg J. Righteous Dopefiend 2009, University of California Press, Berkeley.
4. Darke S., Kaye S., Ross J. Geographical injecting locations among injecting drug users in Sydney, Australia. Addiction 2001, 96:241-246.
5. DeBeck K., Small W., Wood E., Li K., Montaner J.S.G., Kerr T. Public injecting among a cohort of injecting drug users in Vancouver, Canada. Journal of Epidemiology and Community Health 2009, 63:81-86.
6. Dovey K., Fitzgerald J., Choi Y. Safety becomes danger: dilemmas of drug-use in public space. Health and Place 2001, 7:319-331.
7. Duff C. The drifting city; the role of affect and repair in the development of 'enabling environments'. International Journal of Drug Policy 2009, 20:202-208.
8. Fairbairn N., Small W., Shannon K., Wood E., Kerr T. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility. Social Science and Medicine 2008, 67:817-823.
9. Fast D., Small W., Wood E., Kerr T. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduction Journal 2008, 5:32.
10. Fawaz M. Neoliberal urbanity and the right to the city: a view from Beirut's periphery. Development and Change 2009, 40:827-852.
11. Fitzgerald J.L. Policing as public health menace in the policy struggles over public injecting. International Journal of Drug Policy 2005, 16:203-206.
12. Fitzgerald J., Dovey K., Dietze P., Rumbold G. Health outcomes and quasi-supervised settings for street injecting drug use. International Journal of Drug Policy 2004, 15:247-257.
13. Freeman K., Jones C.G.A., Weatherburn D.J., Rutter S., Spooner C., Donnelly N. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug and Alcohol Review 2005, 23:173-184.
14. Friedman S.R., Furst R.T., Jose B., Curtis R., Neaigus A., Des Jarlais D.C., Goldstein M.F., Ildefonso G. Drug scene roles and HIV risk. Addiction 1998, 93:1403-1416.
15. Fry C.L. Injecting drug user attitudes towards rules for supervised injecting rooms: implications for uptake. International Journal of Drug Policy 2002, 13:471-476.
16. Gossop M., Griffiths P., Williamson S., Fountain J., Strang J. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors. AIDS Care 1997, 9:651-660.
17. Green T., Hankins C., Palmer D., Boivin J.-F., Platt R. Ascertaining the need for a Safer Injecting Facility (SIF): the burden of public injecting in Montreal, Canada. Journal of Drug Issues 2003, 713-732.
18. HM Government Drugs: protecting families and communities: The 2008 drug strategy 2008, Home Office, London.
19. Haemmig R., Van Beek I. Supervised injecting rooms. Injecting Illicit Drugs 2005, Blackwell Publishing (Addiction Press), London. R. Pates, A. McBride, K. Arnold (Eds.).
20. Hanley S. Estates: An Intimate History 2008, Granta Books, London.
21. Hockey J. 'Switch on': sensory work in the infantry. Work, Employment and Society 2009, 23:477-493.
22. Hunt N., Lloyd C., Kimber J., Tompkins C. Public injecting and willingness to use a drug consumption room among needle exchange programme attendees in the UK. International Journal of Drug Policy 2007, 18:62-65.
23. Inman, M., 2011. Drug-user patrols plan. The Canberra Times. 23 January 2011.
24. Islam M.M., Conigrave K.M. Syringe vending machines as a form of needle syringe programme: advantages and disadvantages. Journal of Substance Use 2007, 12:203-212.
25. Kerr T., Stoltz J., Tyndall M.W., Li K., Zhang R., Montaner J.S.G., Wood E. Impact of a medically supervised injection facility on community drug use patterns: a before and after study. British Medical Journal 2006, 332:220-222.
26. Klee H., Morris J. Factors that characterize street injectors. Addiction 1995, 90:837-841.
27. Layard A. Shopping in the public realm: a law of place. Journal of Law and Society 2010, 37:412-441.
28. Lefebvre H. The Production of Space 1991, Blackwell Publishing, Oxford.
29. Lefebvre H. Writing on Cities 1996, Blackwell Publishing, Oxford.
30. Malkin I. Establishing supervised injecting facilities: a responsible way to minimise harm 2001, Melbourne University Law Review 25, pp. 680-756.
31. Marshall B.D., Kerr T., Qi J., Montaner J.S.G., Wood E. Public injecting and HIV risk behaviour among street-involved youth. Drug and Alcohol Dependence 2010, 110:254-258.
32. McCann E.J. Race, Protest and Public Space: Contextualizing Lefebvre in the US City. Antipode 1999, 31:163-184.
33. McKnight I., Maas B., Wood E., Tyndall M.W., Small W., Lai C., Montaner J.S.G., Kerr T. Factors associated with public injecting among users of Vancouver's Supervised Injecting Facility. American Journal of Drug and Alcohol Abuse 2007, 33:319-326.
34. Mitchell D. The Right to the City: Social Justice and the Fight for Public Space 2003, The Guilford Press, London.
35. Moore D., Dietze P. Enabling environments and the reduction of drug-related harm: re-framing Australian policy and practice. Drug and Alcohol Review 2005, 24:275-284.
36. Nagle J. Sites of social centrality and segregation: Lefebvre in Belfast, a "Divided City". Antipode 2009, 41:326-347.
37. Navarro C., Leonard L. Prevalence and factors related to public injecting in Ottawa, Canada: implications for the development of a trial safer injecting facility. International Journal of Drug Policy 2004, 15:275-284.
38. Parkin, S., 2009. The Effects of Place on Health Risk: A Qualitative Study of Micro-injecting Environments (PhD Thesis). Faculty of Health. University of Plymouth, Plymouth.
39. Parkin, S., 2010. Habitus and the Logic of Practice in the Field of Public Injecting Drug Use. In: Paper Presentation at British Sociological Association Annual Conference, Glasgow Caledonian University, Glasgow, 7-9 April.
40. Parkin S., Coomber R. 'Informal sorter houses': a qualitative insight of the 'shooting gallery' phenomenon in a UK setting. Health and Place 2009, 15:981-989.
41. Parkin S., Coomber R. Public injecting and symbolic violence. Addiction Research and Theory 2009, 17:390-405.
42. Parkin S., Coomber R. Fluorescent blue lights, injecting drug use and related health risk: findings from a qualitative study of micro-injecting environments. Health and Place 2010, 16:629-637.
43. Parkin S., Coomber R., Wallace G. Going Public. Drink and Drug News, London 2010, 14-15.
44. Pearson M., Parkin S., Coomber R. The transferability of harm reduction via a street-based typology developed through qualitative research. Contemporary Drug Problems 2011, 38.
45. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. International Journal of Drug Policy 2002, 13:85-94.
46. Rhodes T., Singer M., Bourgois P., Friedman S.R., Strathdee S.A. The social structural production of HIV risk among injecting drug users. Social Science and Medicine 2005, 61:1026-1044.
47. Rhodes T., Watts L., Davies S., Martin A., Smith J., Clark D., Craine N., Lyons M. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales. Social Science and Medicine 2007, 65:572-585.
48. Rhodes T., Zikic B., Prodanovic A., Kuneski E., Bernays S. Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia. Social Science and Medicine 2008, 66:1437-1447.
49. Salmon A.M., Dwyer R., Jauncey M., Van Beek I., Topp L., Maher L. Injecting-related injury and disease among clients of a supervised injecting facility. Drug and Alcohol Dependence 2009, 101:132-136.
50. Salmon A.M., Van Beek I., Amin J., Kaldor J., Maher L. The impact of a supervised injecting facility on ambulance call outs in Sydney, Australia. Addiction 2010, 105:676-683.
51. Small W., Rhodes T., Wood E., Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. International Journal of Drug Policy 2007, 18:27-36.
52. Stoltz J., Wood E., Small W., Li K., Tyndall M., Montaner J.S.G., Kerr T. Changes in injecting practices associated with the use of a medically supervised safer injection facility. Journal of Public Health 2007, 29:35-39.
53. Taylor, A., Cusick, L., Kimber, J., Rutherford, J., Hickman, M., Rhodes, T., 2006. The social impact of public injecting (Independent Working Group on Drug Consumption Rooms). Joseph Rowntree Foundation. p. Paper D.
54. Taylor A., Fleming A., Rutherford J., Goldberg D. Examining the injecting practices of injecting drug users in Scotland 2004, Effective Interventions Unit, Scottish Office, Edinburgh.
55. van Beek I., Kimber J., Dakin A., Gilmour S. The Sydney medically supervised injecting centre: reducing harm associated with heroin overdose. Critical Public Health 2004, 14:391-406.
56. Wood E., Kerr T., Small D., Li K., Marsh D.C., Montaner J.S.G., Tyndall M.W. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Canadian Medical Association Journal 2004, 171:731-734.